Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Apr;73(4):885-892.
doi: 10.1161/HYPERTENSIONAHA.118.12070.

Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks

Affiliations
Multicenter Study

Genetic Characteristics of Aldosterone-Producing Adenomas in Blacks

Kazutaka Nanba et al. Hypertension. 2019 Apr.

Abstract

Somatic mutations have been identified in aldosterone-producing adenomas (APAs) in genes that include KCNJ5, ATP1A1, ATP2B3, and CACNA1D. Based on independent studies, there appears to be racial differences in the prevalence of somatic KCNJ5 mutations, particularly between East Asians and Europeans. Despite the high cardiovascular disease mortality of blacks, there have been no studies focusing on somatic mutations in APAs in this population. In the present study, we investigated genetic characteristics of APAs in blacks using a CYP11B2 (aldosterone synthase) immunohistochemistry-guided next-generation sequencing approach. The adrenal glands with adrenocortical adenomas from 79 black patients with primary aldosteronism were studied. Seventy-three tumors from 69 adrenal glands were confirmed to be APAs by CYP11B2 immunohistochemistry. Sixty-five of 73 APAs (89%) had somatic mutations in aldosterone-driver genes. Somatic CACNA1D mutations were the most prevalent genetic alteration (42%), followed by KCNJ5 (34%), ATP1A1 (8%), and ATP2B3 mutations (4%). CACNA1D mutations were more often observed in APAs from males than those from females (55% versus 29%, P=0.033), whereas KCNJ5 mutations were more prevalent in APAs from females compared with those from males (57% versus 13%, P<0.001). No somatic mutations in aldosterone-driver genes were identified in tumors without CYP11B2 expression. In conclusion, 89% of APAs in blacks harbor aldosterone-driving mutations, and unlike Europeans and East Asians, the most frequently mutated aldosterone-driver gene was CACNA1D. Determination of racial differences in the prevalence of aldosterone-driver gene mutations may facilitate the development of personalized medicines for patients with primary aldosteronism.

Keywords: adrenal glands; adrenocortical adenoma; aldosterone; hyperaldosteronism; mutation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Study design based on the results of CYP11B2 immunohistochemistry
CYP11B2-expressing tumors were considered as aldosterone-producing adenomas (APAs) by CYP11B2 immunohistochemistry (IHC). *Four adrenals had two independent APAs within the same adrenal; †Ten CYP11B2-negative tumors adjacent to APAs were also assessed. FFPE, formalin-fixed paraffin-embedded.
Figure 2.
Figure 2.. Histopathologic findings of multiple APAs and a CYP11B2-negative adrenocortical adenoma within the same adrenal gland
A and B. Scanned images of adrenal gland and tumors following CYP11B2 IHC (brown, CYP11B2). Two FFPE blocks were used for examination (A, block 1; B, block 2). Scale bar, 5 mm. C-E. High magnification view of each tumor (C, APA1; D, APA2; E, T1). APA1 is mostly composed of lipid-rich clear cells with moderate expression of CYP11B1 as well as high CYP11B2, whereas APA2 is mainly composed of lipid-poor compact cells with intense CYP11B2 expression. Scale bar, 100 μm. H&E, hematoxylin and eosin staining; APA, aldosterone-producing adenoma; T1, CYP11B2-negative tumor.
Figure 3.
Figure 3.. Histopathologic findings of multple aldosterone-producing cell clusters and a CYP11B2-negative adrenocortical adenoma
A and B. Scanned images of adrenal gland following IHC for CYP11B2 (A) and CYP11B1 (B); Scale bar, 5 mm. C-E. Higher magnification view of APCC1 (C), APCC 2 (D), and the CYP11B2-negative tumor (T1; E). Scale bar, 100 μm. H&E, hematoxylin and eosin staining; APCC, aldosterone-producing cell cluster.

References

    1. Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Akerstrom G, Wang W, Carling T and Lifton RP. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768–772. doi: 10.1126/science.1198785 - DOI - PMC - PubMed
    1. Beuschlein F, Boulkroun S, Osswald A, Wieland T, Nielsen HN, Lichtenauer UD, Penton D, Schack VR, Amar L, Fischer E, Walther A, Tauber P, Schwarzmayr T, Diener S, Graf E, Allolio B, Samson-Couterie B, Benecke A, Quinkler M, Fallo F, Plouin PF, Mantero F, Meitinger T, Mulatero P, Jeunemaitre X, Warth R, Vilsen B, Zennaro MC, Strom TM and Reincke M. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440–444, 444e441-442. doi: 10.1038/ng.2550 - DOI - PubMed
    1. Scholl UI, Goh G, Stolting G, de Oliveira RC, Choi M, Overton JD, Fonseca AL, Korah R, Starker LF, Kunstman JW, Prasad ML, Hartung EA, Mauras N, Benson MR, Brady T, Shapiro JR, Loring E, Nelson-Williams C, Libutti SK, Mane S, Hellman P, Westin G, Akerstrom G, Bjorklund P, Carling T, Fahlke C, Hidalgo P and Lifton RP. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050–1054. doi: 10.1038/ng.2695 - DOI - PMC - PubMed
    1. Azizan EAB, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AED, Davenport AP, Dekkers T, Tops B, Kusters B, Ceral J, Yeo GSH, Neogi SG, McFarlane I, Rosenfeld N, Marass F, Hadfield J, Margas W, Chaggar K, Solar M, Deinum J, Dolphin AC, Farooqi IS, Striessnig J, Nissen P and Brown MJ. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055–1060. doi: 10.1038/ng.2716 - DOI - PubMed
    1. Scholl UI, Stolting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C and Lifton RP. Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. 2015;4:e06315. doi: 10.7554/eLife.06315 - DOI - PMC - PubMed

Publication types

MeSH terms